# C3.ai timeline entity: /record/c3-ai.md id: ent_c3-ai ## undated - undated | ticker | AI | valid | [clm_0E3A2D3B02E5](/claim/clm_0E3A2D3B02E5.md) - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_443DCDF30FB6](/claim/clm_443DCDF30FB6.md) - undated | listed_on | NYSE | valid | [clm_5725C20CED3A](/claim/clm_5725C20CED3A.md) - undated | state_of_incorporation | DE | valid | [clm_82D74222C82F](/claim/clm_82D74222C82F.md) - undated | fiscal_year_end | 04-30 | valid | [clm_8DD337428BB1](/claim/clm_8DD337428BB1.md) - undated | cik | 0001577526 | valid | [clm_EA0EFB9BC28C](/claim/clm_EA0EFB9BC28C.md) - undated to 2013-05-29 | registrant_name | C3.ai, Inc. | superseded | [clm_EE32B2FE4A55](/claim/clm_EE32B2FE4A55.md) - undated | legal_form | Delaware corporation | unverified | [clm_17D851E323A8](/claim/clm_17D851E323A8.md) - undated | website | http://www.c3.ai/ | unverified | [clm_4E23793EC0D2](/claim/clm_4E23793EC0D2.md) ## 2009 - 2009-10-07 | x_username | C3_AI | unverified | [clm_95BC324275CA](/claim/clm_95BC324275CA.md) ## 2013 - 2013-05-29 to 2013-05-29 | registrant_name | C3, Inc. | superseded | [clm_71CBCEF62A24](/claim/clm_71CBCEF62A24.md) ## 2018 - 2018-03-26 to 2018-03-26 | registrant_name | C3 IoT, Inc. | superseded | [clm_B75A1364B810](/claim/clm_B75A1364B810.md) - 2018-04-30 to 2019-04-30 | total_equity | -139,830,000 United States dollar | superseded | [clm_E4CE620154F2](/claim/clm_E4CE620154F2.md) ## 2019 - 2019-04-30 to 2020-01-31 | cash_and_equivalents | 98,607,000 United States dollar | superseded | [clm_1B08F22C849C](/claim/clm_1B08F22C849C.md) - 2019-04-30 to 2020-04-30 | net_income | -33,346,000 United States dollar | superseded | [clm_1FCD47235071](/claim/clm_1FCD47235071.md) - 2019-04-30 to 2020-04-30 | revenue | 91,605,000 United States dollar | superseded | [clm_35E5C22AACCF](/claim/clm_35E5C22AACCF.md) - 2019-04-30 to 2020-04-30 | research_and_development | 37,318,000 United States dollar | superseded | [clm_42123057E63F](/claim/clm_42123057E63F.md) - 2019-04-30 to 2019-10-31 | total_equity | -165,434,000 United States dollar | superseded | [clm_A9EADA6FAC4B](/claim/clm_A9EADA6FAC4B.md) - 2019-04-30 to 2020-04-30 | operating_income | -36,042,000 United States dollar | superseded | [clm_D6A17A20871A](/claim/clm_D6A17A20871A.md) - 2019-10-31 to 2020-01-31 | total_equity | -148,833,000 United States dollar | superseded | [clm_EA9D3293343D](/claim/clm_EA9D3293343D.md) ## 2020 - 2020-01-31 to 2020-07-31 | quarterly_research_and_development | 12,331,000 United States dollar | superseded | [clm_3AA3614C71DB](/claim/clm_3AA3614C71DB.md) - 2020-01-31 to 2020-07-31 | quarterly_operating_income | -10,432,000 United States dollar | superseded | [clm_6302FAE94DB0](/claim/clm_6302FAE94DB0.md) - 2020-01-31 to 2020-04-30 | total_equity | -155,897,000 United States dollar | superseded | [clm_96ED131D6F47](/claim/clm_96ED131D6F47.md) - 2020-01-31 to 2020-07-31 | quarterly_net_income | -9,796,000 United States dollar | superseded | [clm_B1C7AA671DB8](/claim/clm_B1C7AA671DB8.md) - 2020-01-31 to 2020-04-30 | cash_and_equivalents | 50,343,000 United States dollar | superseded | [clm_D5A10126940D](/claim/clm_D5A10126940D.md) - 2020-01-31 to 2020-07-31 | quarterly_revenue | 41,283,000 United States dollar | superseded | [clm_F9D3BEA63B3A](/claim/clm_F9D3BEA63B3A.md) - 2020-04-30 to 2021-04-30 | net_income | -69,378,000 United States dollar | superseded | [clm_00E11518F0E9](/claim/clm_00E11518F0E9.md) - 2020-04-30 to 2021-01-31 | total_assets | 305,108,000 United States dollar | superseded | [clm_048D84FF6D5D](/claim/clm_048D84FF6D5D.md) - 2020-04-30 to 2021-04-30 | research_and_development | 64,548,000 United States dollar | superseded | [clm_19FA5822C9C2](/claim/clm_19FA5822C9C2.md) - 2020-04-30 to 2021-04-30 | revenue | 156,666,000 United States dollar | superseded | [clm_5EFBEBBA4F11](/claim/clm_5EFBEBBA4F11.md) - 2020-04-30 to 2020-07-31 | cash_and_equivalents | 33,104,000 United States dollar | superseded | [clm_7EB30B9504D5](/claim/clm_7EB30B9504D5.md) - 2020-04-30 to 2020-07-31 | total_equity | -182,697,000 United States dollar | superseded | [clm_E5BFBC866058](/claim/clm_E5BFBC866058.md) - 2020-04-30 to 2021-04-30 | operating_income | -71,497,000 United States dollar | superseded | [clm_F2EFE8B45E28](/claim/clm_F2EFE8B45E28.md) - 2020-07-31 to 2020-10-31 | cash_and_equivalents | 128,979,000 United States dollar | superseded | [clm_31AEEFAD4E37](/claim/clm_31AEEFAD4E37.md) - 2020-07-31 to 2020-10-31 | quarterly_revenue | 40,483,000 United States dollar | superseded | [clm_3239E4922C03](/claim/clm_3239E4922C03.md) - 2020-07-31 to 2020-10-31 | quarterly_operating_income | -3,325,000 United States dollar | superseded | [clm_39BFED39F959](/claim/clm_39BFED39F959.md) - 2020-07-31 to 2020-10-31 | quarterly_net_income | 150,000 United States dollar | superseded | [clm_A44F938338C2](/claim/clm_A44F938338C2.md) - 2020-07-31 to 2020-10-31 | quarterly_research_and_development | 13,264,000 United States dollar | superseded | [clm_F3B9878A29D4](/claim/clm_F3B9878A29D4.md) - 2020-07-31 to 2020-10-31 | total_equity | -179,681,000 United States dollar | superseded | [clm_FCDD7F72A673](/claim/clm_FCDD7F72A673.md) - 2020-10-31 to 2021-01-31 | quarterly_revenue | 41,341,000 United States dollar | superseded | [clm_0A37C5166321](/claim/clm_0A37C5166321.md) - 2020-10-31 to 2021-01-31 | total_equity | -184,327,000 United States dollar | superseded | [clm_5FBCC3A5C472](/claim/clm_5FBCC3A5C472.md) - 2020-10-31 to 2021-01-31 | quarterly_research_and_development | 16,134,000 United States dollar | superseded | [clm_968378773E73](/claim/clm_968378773E73.md) - 2020-10-31 to 2021-01-31 | quarterly_net_income | -14,944,000 United States dollar | superseded | [clm_DD3756AD65B4](/claim/clm_DD3756AD65B4.md) - 2020-10-31 to 2021-01-31 | quarterly_operating_income | -14,524,000 United States dollar | superseded | [clm_E57D595B1DA9](/claim/clm_E57D595B1DA9.md) - 2020-10-31 to 2021-01-31 | cash_and_equivalents | 114,603,000 United States dollar | superseded | [clm_F89A3435E9E5](/claim/clm_F89A3435E9E5.md) ## 2021 - 2021-01-31 to 2021-04-30 | total_equity | 1,074,112,000 United States dollar | superseded | [clm_0AC80264466D](/claim/clm_0AC80264466D.md) - 2021-01-31 to 2021-04-30 | total_assets | 1,184,574,000 United States dollar | superseded | [clm_0E3D2422EAAB](/claim/clm_0E3D2422EAAB.md) - 2021-01-31 to 2021-04-30 | cash_and_equivalents | 960,122,000 United States dollar | superseded | [clm_249DEB35E487](/claim/clm_249DEB35E487.md) - 2021-01-31 to 2021-07-31 | quarterly_revenue | 49,109,000 United States dollar | superseded | [clm_6158517BD570](/claim/clm_6158517BD570.md) - 2021-01-31 to 2021-07-31 | quarterly_net_income | -16,852,000 United States dollar | superseded | [clm_6FECD3F8C57E](/claim/clm_6FECD3F8C57E.md) - 2021-01-31 to 2021-07-31 | quarterly_research_and_development | 18,748,000 United States dollar | superseded | [clm_94F2D69C8AC9](/claim/clm_94F2D69C8AC9.md) - 2021-01-31 to 2021-07-31 | quarterly_operating_income | -18,499,000 United States dollar | superseded | [clm_F1BBF96A6BE4](/claim/clm_F1BBF96A6BE4.md) - 2021-04-30 to 2022-04-30 | operating_income | -60,258,000 United States dollar | superseded | [clm_32234D730ABE](/claim/clm_32234D730ABE.md) - 2021-04-30 to 2022-04-30 | revenue | 183,217,000 United States dollar | superseded | [clm_6CD6AE44358C](/claim/clm_6CD6AE44358C.md) - 2021-04-30 to 2022-04-30 | research_and_development | 68,856,000 United States dollar | superseded | [clm_A1461D542939](/claim/clm_A1461D542939.md) - 2021-04-30 to 2022-04-30 | net_income | -55,696,000 United States dollar | superseded | [clm_ABD27C6290EF](/claim/clm_ABD27C6290EF.md) - 2021-04-30 to 2021-07-31 | total_assets | 1,196,477,000 United States dollar | superseded | [clm_B90A441513B2](/claim/clm_B90A441513B2.md) - 2021-04-30 to 2021-07-31 | cash_and_equivalents | 115,355,000 United States dollar | superseded | [clm_D025D10B8232](/claim/clm_D025D10B8232.md) - 2021-04-30 to 2021-07-31 | total_equity | 1,061,175,000 United States dollar | superseded | [clm_E6C20E85DB99](/claim/clm_E6C20E85DB99.md) - 2021-07-31 to 2021-10-31 | total_equity | 1,043,795,000 United States dollar | superseded | [clm_2C0C971FBF05](/claim/clm_2C0C971FBF05.md) - 2021-07-31 to 2021-10-31 | quarterly_net_income | -37,459,000 United States dollar | superseded | [clm_4334C7FC2A43](/claim/clm_4334C7FC2A43.md) - 2021-07-31 to 2021-10-31 | quarterly_revenue | 52,406,000 United States dollar | superseded | [clm_4E3689626351](/claim/clm_4E3689626351.md) - 2021-07-31 to 2021-10-31 | cash_and_equivalents | 273,779,000 United States dollar | superseded | [clm_519526F743C5](/claim/clm_519526F743C5.md) - 2021-07-31 to 2021-10-31 | total_assets | 1,191,540,000 United States dollar | superseded | [clm_676FE01FFFD6](/claim/clm_676FE01FFFD6.md) - 2021-07-31 to 2021-10-31 | quarterly_research_and_development | 26,712,000 United States dollar | superseded | [clm_8FAC25432530](/claim/clm_8FAC25432530.md) - 2021-07-31 to 2021-10-31 | quarterly_operating_income | -36,517,000 United States dollar | superseded | [clm_B1DC2763C7F4](/claim/clm_B1DC2763C7F4.md) - 2021-10-31 to 2022-01-31 | total_assets | 1,164,870,000 United States dollar | superseded | [clm_52AAD590BFF5](/claim/clm_52AAD590BFF5.md) - 2021-10-31 to 2022-01-31 | quarterly_revenue | 58,263,000 United States dollar | superseded | [clm_8629ACD8A40A](/claim/clm_8629ACD8A40A.md) - 2021-10-31 to 2022-01-31 | quarterly_net_income | -56,739,000 United States dollar | superseded | [clm_9FC7F1043BF4](/claim/clm_9FC7F1043BF4.md) - 2021-10-31 to 2022-01-31 | quarterly_operating_income | -55,676,000 United States dollar | superseded | [clm_A63001772217](/claim/clm_A63001772217.md) - 2021-10-31 to 2022-01-31 | total_equity | 1,026,510,000 United States dollar | superseded | [clm_F75977FE5C5C](/claim/clm_F75977FE5C5C.md) - 2021-10-31 to 2022-01-31 | quarterly_research_and_development | 36,523,000 United States dollar | superseded | [clm_F8178F54B280](/claim/clm_F8178F54B280.md) - 2021-10-31 to 2022-01-31 | cash_and_equivalents | 167,436,000 United States dollar | superseded | [clm_FD79753C0BF7](/claim/clm_FD79753C0BF7.md) ## 2022 - 2022-01-31 to 2022-07-31 | quarterly_revenue | 69,773,000 United States dollar | superseded | [clm_7783084FA512](/claim/clm_7783084FA512.md) - 2022-01-31 to 2022-04-30 | cash_and_equivalents | 204,531,000 United States dollar | superseded | [clm_9AC116CCF624](/claim/clm_9AC116CCF624.md) - 2022-01-31 to 2022-07-31 | quarterly_net_income | -39,447,000 United States dollar | superseded | [clm_9E7F2A6316B2](/claim/clm_9E7F2A6316B2.md) - 2022-01-31 to 2022-07-31 | quarterly_research_and_development | 40,931,000 United States dollar | superseded | [clm_A5DC934A4C87](/claim/clm_A5DC934A4C87.md) - 2022-01-31 to 2022-04-30 | total_assets | 1,187,507,000 United States dollar | superseded | [clm_CDF580B45521](/claim/clm_CDF580B45521.md) - 2022-01-31 to 2022-04-30 | total_equity | 1,026,675,000 United States dollar | superseded | [clm_CFD24EEEECF8](/claim/clm_CFD24EEEECF8.md) - 2022-01-31 to 2022-07-31 | quarterly_operating_income | -47,406,000 United States dollar | superseded | [clm_F1D8A63AB4F3](/claim/clm_F1D8A63AB4F3.md) - 2022-04-30 to 2023-04-30 | research_and_development | 150,544,000 United States dollar | superseded | [clm_34EC51B53462](/claim/clm_34EC51B53462.md) - 2022-04-30 to 2023-04-30 | operating_income | -196,122,000 United States dollar | superseded | [clm_35021080CBE1](/claim/clm_35021080CBE1.md) - 2022-04-30 to 2022-07-31 | cash_and_equivalents | 339,528,000 United States dollar | superseded | [clm_9AE68AF55E9F](/claim/clm_9AE68AF55E9F.md) - 2022-04-30 to 2022-07-31 | total_assets | 1,170,882,000 United States dollar | superseded | [clm_A0CA52E8FCE9](/claim/clm_A0CA52E8FCE9.md) - 2022-04-30 to 2023-04-30 | net_income | -192,065,000 United States dollar | superseded | [clm_E62478E6111C](/claim/clm_E62478E6111C.md) - 2022-04-30 to 2023-04-30 | revenue | 252,759,000 United States dollar | superseded | [clm_F1C514360DEB](/claim/clm_F1C514360DEB.md) - 2022-04-30 to 2022-07-31 | total_equity | 989,477,000 United States dollar | superseded | [clm_FCD8764369B5](/claim/clm_FCD8764369B5.md) - 2022-07-31 to 2022-10-31 | quarterly_revenue | 65,308,000 United States dollar | superseded | [clm_10B05AAB75F7](/claim/clm_10B05AAB75F7.md) - 2022-07-31 to 2022-10-31 | total_assets | 1,137,169,000 United States dollar | superseded | [clm_6C7B2E004177](/claim/clm_6C7B2E004177.md) - 2022-07-31 to 2022-10-31 | quarterly_operating_income | -73,209,000 United States dollar | superseded | [clm_85C9E7AA5992](/claim/clm_85C9E7AA5992.md) - 2022-07-31 to 2022-10-31 | quarterly_research_and_development | 55,877,000 United States dollar | superseded | [clm_A818F31EB40D](/claim/clm_A818F31EB40D.md) - 2022-07-31 to 2022-10-31 | cash_and_equivalents | 221,883,000 United States dollar | superseded | [clm_B8D5E4114259](/claim/clm_B8D5E4114259.md) - 2022-07-31 to 2022-10-31 | total_equity | 978,978,000 United States dollar | superseded | [clm_EC6C9F1D86A6](/claim/clm_EC6C9F1D86A6.md) - 2022-07-31 to 2022-10-31 | quarterly_net_income | -71,871,000 United States dollar | superseded | [clm_FA8E03EA6604](/claim/clm_FA8E03EA6604.md) - 2022-10-31 to 2023-01-31 | total_assets | 1,100,605,000 United States dollar | superseded | [clm_0080A0C12F37](/claim/clm_0080A0C12F37.md) - 2022-10-31 to 2023-01-31 | quarterly_operating_income | -71,966,000 United States dollar | superseded | [clm_1C26E7560EB2](/claim/clm_1C26E7560EB2.md) - 2022-10-31 to 2023-01-31 | cash_and_equivalents | 277,622,000 United States dollar | superseded | [clm_369C9CBA0B4C](/claim/clm_369C9CBA0B4C.md) - 2022-10-31 to 2023-01-31 | quarterly_revenue | 62,408,000 United States dollar | superseded | [clm_9CC80B9B98C8](/claim/clm_9CC80B9B98C8.md) - 2022-10-31 to 2023-01-31 | total_equity | 953,166,000 United States dollar | superseded | [clm_C0CE02ABFC51](/claim/clm_C0CE02ABFC51.md) - 2022-10-31 to 2023-01-31 | quarterly_research_and_development | 50,051,000 United States dollar | superseded | [clm_C521AB9B53FC](/claim/clm_C521AB9B53FC.md) - 2022-10-31 to 2023-01-31 | quarterly_net_income | -68,850,000 United States dollar | superseded | [clm_CE9580EC90C8](/claim/clm_CE9580EC90C8.md) ## 2023 - 2023-01-31 to 2023-07-31 | quarterly_research_and_development | 55,051,000 United States dollar | superseded | [clm_28743FD917D3](/claim/clm_28743FD917D3.md) - 2023-01-31 to 2023-04-30 | cash_and_equivalents | 311,142,000 United States dollar | superseded | [clm_48C44CBDE784](/claim/clm_48C44CBDE784.md) - 2023-01-31 to 2023-07-31 | quarterly_revenue | 66,669,000 United States dollar | superseded | [clm_83EE8F06C816](/claim/clm_83EE8F06C816.md) - 2023-01-31 to 2023-04-30 | total_assets | 1,095,213,000 United States dollar | superseded | [clm_9CB8B4BC1783](/claim/clm_9CB8B4BC1783.md) - 2023-01-31 to 2023-07-31 | quarterly_operating_income | -72,038,000 United States dollar | superseded | [clm_9DAFD5171AFB](/claim/clm_9DAFD5171AFB.md) - 2023-01-31 to 2023-04-30 | total_equity | 947,370,000 United States dollar | superseded | [clm_AD76373AEC80](/claim/clm_AD76373AEC80.md) - 2023-01-31 to 2023-07-31 | quarterly_net_income | -63,162,000 United States dollar | superseded | [clm_AFF501437633](/claim/clm_AFF501437633.md) - 2023-02-28 | board_member | K.R. Sridhar | valid | [clm_E7C437A35A31](/claim/clm_E7C437A35A31.md) - 2023-04-30 to 2023-07-31 | cash_and_equivalents | 284,829,000 United States dollar | superseded | [clm_08A3C8480B80](/claim/clm_08A3C8480B80.md) - 2023-04-30 to 2024-04-30 | operating_income | -290,493,000 United States dollar | superseded | [clm_1D3CE2ED2F1A](/claim/clm_1D3CE2ED2F1A.md) - 2023-04-30 to 2024-04-30 | net_income | -268,839,000 United States dollar | superseded | [clm_47CDA7724861](/claim/clm_47CDA7724861.md) - 2023-04-30 to 2023-07-31 | total_assets | 1,103,028,000 United States dollar | superseded | [clm_4BF666357B94](/claim/clm_4BF666357B94.md) - 2023-04-30 to 2023-07-31 | total_equity | 929,665,000 United States dollar | superseded | [clm_C9AF6162185B](/claim/clm_C9AF6162185B.md) - 2023-04-30 to 2024-04-30 | revenue | 266,795,000 United States dollar | superseded | [clm_D85AFE63BE2A](/claim/clm_D85AFE63BE2A.md) - 2023-04-30 to 2024-04-30 | research_and_development | 210,660,000 United States dollar | superseded | [clm_F59E87D72E9F](/claim/clm_F59E87D72E9F.md) - 2023-07-31 to 2023-10-31 | cash_and_equivalents | 206,442,000 United States dollar | superseded | [clm_398A30593769](/claim/clm_398A30593769.md) - 2023-07-31 to 2023-10-31 | total_assets | 1,089,403,000 United States dollar | superseded | [clm_75C92A81D5C8](/claim/clm_75C92A81D5C8.md) - 2023-07-31 to 2023-10-31 | quarterly_research_and_development | 50,868,000 United States dollar | superseded | [clm_79D650CE96B5](/claim/clm_79D650CE96B5.md) - 2023-07-31 to 2023-10-31 | quarterly_operating_income | -74,093,000 United States dollar | superseded | [clm_95D7A925B753](/claim/clm_95D7A925B753.md) - 2023-07-31 to 2023-10-31 | quarterly_net_income | -64,358,000 United States dollar | superseded | [clm_B64C687737A8](/claim/clm_B64C687737A8.md) - 2023-07-31 to 2023-10-31 | total_equity | 932,442,000 United States dollar | superseded | [clm_CA340BEB57DB](/claim/clm_CA340BEB57DB.md) - 2023-07-31 to 2023-10-31 | quarterly_revenue | 72,362,000 United States dollar | superseded | [clm_E3288076F37A](/claim/clm_E3288076F37A.md) - 2023-10-31 to 2024-01-31 | quarterly_net_income | -69,780,000 United States dollar | superseded | [clm_0B845A0DB33D](/claim/clm_0B845A0DB33D.md) - 2023-10-31 to 2024-01-31 | quarterly_revenue | 73,229,000 United States dollar | superseded | [clm_1CBEA1CC5AE9](/claim/clm_1CBEA1CC5AE9.md) - 2023-10-31 to 2024-01-31 | cash_and_equivalents | 149,009,000 United States dollar | superseded | [clm_265FEB89A925](/claim/clm_265FEB89A925.md) - 2023-10-31 to 2024-01-31 | total_assets | 1,071,114,000 United States dollar | superseded | [clm_352F1DF653FF](/claim/clm_352F1DF653FF.md) - 2023-10-31 to 2024-01-31 | total_equity | 911,276,000 United States dollar | superseded | [clm_376C880A70BB](/claim/clm_376C880A70BB.md) - 2023-10-31 to 2024-01-31 | quarterly_operating_income | -79,396,000 United States dollar | superseded | [clm_62DB440367CD](/claim/clm_62DB440367CD.md) - 2023-10-31 to 2024-01-31 | quarterly_research_and_development | 50,399,000 United States dollar | superseded | [clm_86C12CF0BF6B](/claim/clm_86C12CF0BF6B.md) ## 2024 - 2024-01-31 to 2024-07-31 | quarterly_research_and_development | 49,480,000 United States dollar | superseded | [clm_03D83B0E32C6](/claim/clm_03D83B0E32C6.md) - 2024-01-31 to 2024-04-30 | total_equity | 897,995,000 United States dollar | superseded | [clm_100A2FB20DE0](/claim/clm_100A2FB20DE0.md) - 2024-01-31 to 2024-07-31 | quarterly_operating_income | -82,546,000 United States dollar | superseded | [clm_4549D15038E8](/claim/clm_4549D15038E8.md) - 2024-01-31 to 2024-07-31 | quarterly_revenue | 78,401,000 United States dollar | superseded | [clm_888D042AC10B](/claim/clm_888D042AC10B.md) - 2024-01-31 to 2024-04-30 | cash_and_equivalents | 114,561,000 United States dollar | superseded | [clm_D8150790CAFB](/claim/clm_D8150790CAFB.md) - 2024-01-31 to 2024-04-30 | total_assets | 1,063,989,000 United States dollar | superseded | [clm_DE90A978C062](/claim/clm_DE90A978C062.md) - 2024-01-31 to 2024-07-31 | quarterly_net_income | -72,631,000 United States dollar | superseded | [clm_F516E5A6262F](/claim/clm_F516E5A6262F.md) - 2024-04-30 to 2025-04-30 | research_and_development | 201,365,000 United States dollar | superseded | [clm_0E6FFF2A1128](/claim/clm_0E6FFF2A1128.md) - 2024-04-30 to 2025-04-30 | net_income | -279,696,000 United States dollar | superseded | [clm_2551E9C12215](/claim/clm_2551E9C12215.md) - 2024-04-30 to 2025-04-30 | revenue | 310,582,000 United States dollar | superseded | [clm_4F82CBD4D5AD](/claim/clm_4F82CBD4D5AD.md) - 2024-04-30 to 2024-07-31 | total_assets | 1,038,225,000 United States dollar | superseded | [clm_8EFDB4049605](/claim/clm_8EFDB4049605.md) - 2024-04-30 to 2024-07-31 | total_equity | 873,353,000 United States dollar | superseded | [clm_988BA20E97BA](/claim/clm_988BA20E97BA.md) - 2024-04-30 to 2025-04-30 | operating_income | -318,342,000 United States dollar | superseded | [clm_DC29F2F8D924](/claim/clm_DC29F2F8D924.md) - 2024-04-30 to 2024-07-31 | cash_and_equivalents | 167,146,000 United States dollar | superseded | [clm_E327F13F8E67](/claim/clm_E327F13F8E67.md) - 2024-05-01 | board_member | Alan Murray | valid | [clm_31F6466830C8](/claim/clm_31F6466830C8.md) - 2024-06-19 | coo | Merel Witteveen | valid | [clm_41F45F4EF86B](/claim/clm_41F45F4EF86B.md) - 2024-07-31 to 2024-10-31 | quarterly_research_and_development | 52,927,000 United States dollar | superseded | [clm_489353CA33E9](/claim/clm_489353CA33E9.md) - 2024-07-31 to 2024-10-31 | quarterly_net_income | -62,827,000 United States dollar | superseded | [clm_5463AD715D8B](/claim/clm_5463AD715D8B.md) - 2024-07-31 to 2024-10-31 | total_equity | 874,921,000 United States dollar | superseded | [clm_9BB5AFEE9238](/claim/clm_9BB5AFEE9238.md) - 2024-07-31 to 2024-10-31 | quarterly_operating_income | -72,586,000 United States dollar | superseded | [clm_A3DBFAA29657](/claim/clm_A3DBFAA29657.md) - 2024-07-31 to 2024-10-31 | cash_and_equivalents | 133,820,000 United States dollar | superseded | [clm_A63C7C8A85DF](/claim/clm_A63C7C8A85DF.md) - 2024-07-31 to 2024-10-31 | quarterly_revenue | 87,213,000 United States dollar | superseded | [clm_CA7A44041B8B](/claim/clm_CA7A44041B8B.md) - 2024-07-31 to 2024-10-31 | total_assets | 1,057,620,000 United States dollar | superseded | [clm_E8A0E0D21470](/claim/clm_E8A0E0D21470.md) - 2024-10-05 | board_member | John E. Hyten | valid | [clm_502F9E4D3BA8](/claim/clm_502F9E4D3BA8.md) - 2024-10-31 to 2025-01-31 | quarterly_net_income | -65,972,000 United States dollar | superseded | [clm_56E4BDC5547D](/claim/clm_56E4BDC5547D.md) - 2024-10-31 to 2025-01-31 | total_equity | 858,961,000 United States dollar | superseded | [clm_733ABBFD7C83](/claim/clm_733ABBFD7C83.md) - 2024-10-31 to 2025-01-31 | quarterly_operating_income | -75,288,000 United States dollar | superseded | [clm_7C36FBD6230C](/claim/clm_7C36FBD6230C.md) - 2024-10-31 to 2025-01-31 | cash_and_equivalents | 121,274,000 United States dollar | superseded | [clm_A3E9C66CC65A](/claim/clm_A3E9C66CC65A.md) - 2024-10-31 to 2025-01-31 | quarterly_research_and_development | 55,715,000 United States dollar | superseded | [clm_EF465CC1FAEB](/claim/clm_EF465CC1FAEB.md) - 2024-10-31 to 2025-01-31 | quarterly_revenue | 94,338,000 United States dollar | superseded | [clm_F2A474D8BB0C](/claim/clm_F2A474D8BB0C.md) - 2024-10-31 to 2025-01-31 | total_assets | 1,046,289,000 United States dollar | superseded | [clm_F8192F1FF836](/claim/clm_F8192F1FF836.md) ## 2025 - 2025-01-31 to 2025-04-30 | cash_and_equivalents | 125,094,000 United States dollar | superseded | [clm_01A226046961](/claim/clm_01A226046961.md) - 2025-01-31 to 2025-04-30 | total_equity | 860,177,000 United States dollar | superseded | [clm_2B0101DCB48B](/claim/clm_2B0101DCB48B.md) - 2025-01-31 to 2025-07-31 | quarterly_revenue | 98,782,000 United States dollar | superseded | [clm_998FC85257BB](/claim/clm_998FC85257BB.md) - 2025-01-31 to 2025-04-30 | total_assets | 1,055,141,000 United States dollar | superseded | [clm_B63497312846](/claim/clm_B63497312846.md) - 2025-01-31 to 2025-07-31 | quarterly_research_and_development | 59,356,000 United States dollar | superseded | [clm_D31A36B75996](/claim/clm_D31A36B75996.md) - 2025-01-31 to 2025-07-31 | quarterly_operating_income | -87,585,000 United States dollar | superseded | [clm_F08C4E2C1A82](/claim/clm_F08C4E2C1A82.md) - 2025-01-31 to 2025-07-31 | quarterly_net_income | -80,201,000 United States dollar | superseded | [clm_F1B4956D90BC](/claim/clm_F1B4956D90BC.md) - 2025-04-30 to 2025-07-31 | total_assets | 1,025,882,000 United States dollar | superseded | [clm_061604867435](/claim/clm_061604867435.md) - 2025-04-30 to 2025-07-31 | total_equity | 838,303,000 United States dollar | superseded | [clm_0AFE7BBC98E7](/claim/clm_0AFE7BBC98E7.md) - 2025-04-30 to 2026-04-30 | revenue | 389,056,000 United States dollar | superseded | [clm_3A6648C935C8](/claim/clm_3A6648C935C8.md) - 2025-04-30 to 2026-04-30 | operating_income | -324,424,000 United States dollar | superseded | [clm_7429EBFB32E9](/claim/clm_7429EBFB32E9.md) - 2025-04-30 to 2026-04-30 | research_and_development | 226,391,000 United States dollar | superseded | [clm_8E70F86EB493](/claim/clm_8E70F86EB493.md) - 2025-04-30 to 2025-07-31 | cash_and_equivalents | 164,358,000 United States dollar | superseded | [clm_A6FDEF44A692](/claim/clm_A6FDEF44A692.md) - 2025-04-30 to 2026-04-30 | net_income | -288,702,000 United States dollar | superseded | [clm_D38F9CD93774](/claim/clm_D38F9CD93774.md) - 2025-05-21 | board_member | Kenneth A. Goldman | valid | [clm_D68080FB8A97](/claim/clm_D68080FB8A97.md) - 2025-07-31 to 2025-10-31 | total_equity | 798,824,000 United States dollar | superseded | [clm_11A15553CBD8](/claim/clm_11A15553CBD8.md) - 2025-07-31 to 2025-10-31 | cash_and_equivalents | 80,941,000 United States dollar | superseded | [clm_62920273D3EE](/claim/clm_62920273D3EE.md) - 2025-07-31 to 2025-10-31 | total_assets | 968,739,000 United States dollar | superseded | [clm_84321429CC4F](/claim/clm_84321429CC4F.md) - 2025-07-31 to 2025-10-31 | quarterly_operating_income | -124,819,000 United States dollar | superseded | [clm_B13A5D4CFD4E](/claim/clm_B13A5D4CFD4E.md) - 2025-07-31 to 2025-10-31 | quarterly_net_income | -116,769,000 United States dollar | superseded | [clm_BAD6A5261018](/claim/clm_BAD6A5261018.md) - 2025-07-31 to 2025-10-31 | quarterly_research_and_development | 64,651,000 United States dollar | superseded | [clm_E2118950BD70](/claim/clm_E2118950BD70.md) - 2025-07-31 to 2025-10-31 | quarterly_revenue | 70,261,000 United States dollar | superseded | [clm_FFA1745C753A](/claim/clm_FFA1745C753A.md) - 2025-09-01 to 2026-05-08 | ceo | Stephen Ehikian | superseded | [clm_45296E9AFD38](/claim/clm_45296E9AFD38.md) - 2025-10-31 to 2026-01-31 | quarterly_revenue | 75,147,000 United States dollar | superseded | [clm_12E78752406A](/claim/clm_12E78752406A.md) - 2025-10-31 to 2026-01-31 | quarterly_research_and_development | 58,352,000 United States dollar | superseded | [clm_3537BC7B2673](/claim/clm_3537BC7B2673.md) - 2025-10-31 to 2026-01-31 | cash_and_equivalents | 103,205,000 United States dollar | superseded | [clm_3D5B7F9048FD](/claim/clm_3D5B7F9048FD.md) - 2025-10-31 to 2026-01-31 | total_assets | 961,298,000 United States dollar | superseded | [clm_9B19E1656FD5](/claim/clm_9B19E1656FD5.md) - 2025-10-31 to 2026-01-31 | quarterly_net_income | -104,668,000 United States dollar | superseded | [clm_A5A4B303A3FA](/claim/clm_A5A4B303A3FA.md) - 2025-10-31 to 2026-01-31 | total_equity | 771,885,000 United States dollar | superseded | [clm_B3091311BDCD](/claim/clm_B3091311BDCD.md) - 2025-10-31 to 2026-01-31 | quarterly_operating_income | -112,113,000 United States dollar | superseded | [clm_B6E546FF6C0B](/claim/clm_B6E546FF6C0B.md) - 2025-11-09 | board_member | Mike Clayville | valid | [clm_23C5750153DE](/claim/clm_23C5750153DE.md) ## 2026 - 2026-01-31 to 2026-04-30 | cash_and_equivalents | 88,847,000 United States dollar | superseded | [clm_0062BD85017F](/claim/clm_0062BD85017F.md) - 2026-01-31 to 2026-07-31 | quarterly_operating_income | -140,408,000 United States dollar | superseded | [clm_04FE6ED978B4](/claim/clm_04FE6ED978B4.md) - 2026-01-31 to 2026-04-30 | total_assets | 895,776,000 United States dollar | superseded | [clm_106D9F310BB1](/claim/clm_106D9F310BB1.md) - 2026-01-31 to 2026-07-31 | quarterly_revenue | 53,260,000 United States dollar | superseded | [clm_668F77F9D9E4](/claim/clm_668F77F9D9E4.md) - 2026-01-31 to 2026-07-31 | quarterly_research_and_development | 58,823,000 United States dollar | superseded | [clm_A5B9E81DA725](/claim/clm_A5B9E81DA725.md) - 2026-01-31 to 2026-04-30 | total_equity | 719,473,000 United States dollar | superseded | [clm_ADE31CE6E79A](/claim/clm_ADE31CE6E79A.md) - 2026-01-31 to 2026-07-31 | quarterly_net_income | -133,363,000 United States dollar | superseded | [clm_B5863F69958D](/claim/clm_B5863F69958D.md) - 2026-02-24 | restructuring | Restructuring plan: 26% workforce cut and about 30% non-employee cost reduction. | valid | [clm_12BC079D6E86](/claim/clm_12BC079D6E86.md) - 2026-04-30 to 2026-07-31 | cash_and_equivalents | 66,197,000 United States dollar | superseded | [clm_309F1E1C92DB](/claim/clm_309F1E1C92DB.md) - 2026-04-30 | revenue | 250,268,000 United States dollar | valid | [clm_43C25B4938FC](/claim/clm_43C25B4938FC.md) - 2026-04-30 to 2026-07-31 | total_equity | 653,751,000 United States dollar | superseded | [clm_56BFBA674E10](/claim/clm_56BFBA674E10.md) - 2026-04-30 | research_and_development | 229,087,000 United States dollar | valid | [clm_9498151D88B5](/claim/clm_9498151D88B5.md) - 2026-04-30 to 2026-07-31 | total_assets | 816,273,000 United States dollar | superseded | [clm_A13F4DFC5EFF](/claim/clm_A13F4DFC5EFF.md) - 2026-04-30 | operating_income | -498,498,000 United States dollar | valid | [clm_D5E8D97827E5](/claim/clm_D5E8D97827E5.md) - 2026-04-30 | net_income | -470,369,000 United States dollar | valid | [clm_ECC13B0B60CC](/claim/clm_ECC13B0B60CC.md) - 2026-05-08 | chair | Thomas M. Siebel | valid | [clm_801587549812](/claim/clm_801587549812.md) - 2026-05-08 | ceo | Thomas M. Siebel | valid | [clm_B0656EB0BC28](/claim/clm_B0656EB0BC28.md) - 2026-05-08 | president | Stephen Ehikian | valid | [clm_F55F28285CB8](/claim/clm_F55F28285CB8.md) - 2026-07-31 | quarterly_research_and_development | 46,549,000 United States dollar | valid | [clm_21F243534105](/claim/clm_21F243534105.md) - 2026-07-31 | total_assets | 874,804,000 United States dollar | valid | [clm_54CE7F5196D0](/claim/clm_54CE7F5196D0.md) - 2026-07-31 | quarterly_operating_income | -98,268,000 United States dollar | valid | [clm_5C5DCBA56A1D](/claim/clm_5C5DCBA56A1D.md) - 2026-07-31 | total_equity | 694,896,000 United States dollar | valid | [clm_5F2BDE8356BA](/claim/clm_5F2BDE8356BA.md) - 2026-07-31 | quarterly_revenue | 52,375,000 United States dollar | valid | [clm_A7D3C3DA386E](/claim/clm_A7D3C3DA386E.md) - 2026-07-31 | cash_and_equivalents | 136,435,000 United States dollar | valid | [clm_D26067D19993](/claim/clm_D26067D19993.md) - 2026-07-31 | quarterly_net_income | -92,812,000 United States dollar | valid | [clm_ECB7CF4D676F](/claim/clm_ECB7CF4D676F.md) - 2026-08-25 | board_member | John C. Dwyer | valid | [clm_1E9AB1333A09](/claim/clm_1E9AB1333A09.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.